Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000031.xml
Klin Monbl Augenheilkd 2024; 241(04): 426-428
DOI: 10.1055/a-2229-2946
DOI: 10.1055/a-2229-2946
Der interessante Fall
Scleritis and Intraorbital Inflammation following Oral and Intravenous Bisphosphonates in a 66-Year-Old Man
Skleritis und intraorbitale Entzündungen nach oralen und intravenösen Bisphosphonaten bei einem 66-jährigen Mann
Introduction
A recent review has identified 101 reports of bisphosphonate-associated ocular inflammations such as uveitis, scleritis, episcleritis, orbital inflammation, and/or conjunctivitis [1]. In view of the widespread use of these medications to treat osteoporosis, it is important to alert ophthalmologists to these rare ocular manifestations. Therefore, we present a 66-year-old man who developed posterior scleritis and intraorbital inflammation following bisphosphonate treatment for osteoporosis.
Publication History
Received: 28 September 2023
Accepted: 12 December 2023
Article published online:
23 April 2024
© 2024. Thieme. All rights reserved.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References
- 1 Chartrand NA, Lau CK, Parsons MT. et al. Ocular Side Effects of Bisphosphonates: A Review of Literature. J Ocul Pharmacol Ther 2023; 39: 3-16
- 2 [Anonymous] Adverse Drug Reaction Probability Scale (Naranjo) in Drug Induced Liver Injury. In: LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012. Last Update May 4, 2019. Accessed December 19, 2023 at: https://www.ncbi.nlm.nih.gov/books/NBK548069/
- 3 Etiman M, Forooghian F, Maberley D. Inflammatory ocular adverse events with the use of oral bisphosphonates: a retrospective cohort study. CMAJ 2012; 184: e431-e434
- 4 French DD, Margo CE. Postmarketing surveillance rates of uveitis and scleritis with bisphosphonates among a national veteran cohort. Retina 2008; 28: 889-893
- 5 Keren S, Leibovitch I, Ben Cnaan R. et al. Aminobisphosphonate-associated orbital and ocular inflammatory disease. Acta Ophthalmol 2019; 97: e792-e799
- 6 Rifkin LM. Posterior Scleritis: A Diagnostic Challenge. Rev Ophthalmol, published 9 February 2018. Accessed December 19, 2023 at: https://www.reviewofophthalmology.com/article/posterior-scleritis-a-diagnostic-challenge
- 7 Leung S, Ashar BH, Miller RG. Biphosphonate-associated scleritis: a case report and review. South Med J 2005; 98: 733-735